Finance

Lists
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
77,96 $
+1,13%
(+0,87) 1D
78,50 $
+0,69% (+0,54)
After hours
Closed: 7 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KNSA...
Open
76,18 $
High
79,22 $
Low
74,70 $
Mkt. cap
6,08 մլրդ
Avg. vol.
536,15 հզր
Volume
381,04 հզր
P/E ratio
79,31
52-wk high
82,94 $
52-wk low
35,20 $
EPS
0,98 $
Beta
0,04
Shares outstanding
48,29 մլն
No. of employees
366
Open
76,18 $
High
79,22 $
Low
74,70 $
Mkt. cap
6,08 մլրդ
Avg. vol.
536,15 հզր
Volume
381,04 հզր
P/E ratio
79,31
52-wk high
82,94 $
52-wk low
35,20 $
EPS
0,98 $
Beta
0,04
Shares outstanding
48,29 մլն
No. of employees
366
News stories
From web sources and news partners
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersԼոնդոն, Անգլիա, Միացյալ Թագավորություն
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to KNSA in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KNSA in the last 3 months.
Highest
Current 77,96 $
107,00 $ (+37,25%)
Average
96,57 $ (+23,87%)
Lowest
87,00 $ (+11,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yanan Zhu
Wells Fargo
Buy
Maintained
87,00 $
+11,6%
09/29/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
98,00 $
+25,7%
08/12/2026
Paul Choi
Goldman Sachs
Buy
Maintained
90,00 $
+15,4%
07/30/2026
David Nierengarten
Wedbush
Buy
Reiterated
99,00 $
+27%
07/28/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
107,00 $
+37,2%
07/29/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
87,00 $
+11,6%
07/29/2026
Geoff Meacham
Citi
Buy
Maintained
100,00 $
+28,3%
07/29/2026
Nicholas Lorusso
TD Cowen
Buy
Maintained
95,00 $
+21,9%
07/28/2026
Roger Song
Jefferies
Buy
Maintained
71,00 $
-8,9%
04/28/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
53,00 $
-32%
04/14/2026
Last report
28 հլս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,30 $ / 0,28 $
+5,26%beat
Revenue / Est. (USD)
243,60 մլն / 226,46 մլն
+7,57%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
180,86 մլն
202,13 մլն
214,27 մլն
243,60 մլն
Cost of goods sold
83,56 մլն
90,98 մլն
96,37 մլն
111,64 մլն
Cost of revenue
83,56 մլն
90,98 մլն
96,37 մլն
111,64 մլն
Research and development expenses
24,17 մլն
34,61 մլն
27,48 մլն
40,90 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49,10 մլն
56,78 մլն
61,15 մլն
63,87 մլն
Operating expense
73,27 մլն
91,38 մլն
88,63 մլն
104,76 մլն
Total operating expenses
156,83 մլն
182,36 մլն
185,00 մլն
216,41 մլն
Operating income
24,02 մլն
19,77 մլն
29,27 մլն
27,19 մլն
Other non operating income
3,14 մլն
3,50 մլն
3,41 մլն
3,95 մլն
EBT including unusual items
27,16 մլն
23,27 մլն
32,68 մլն
31,14 մլն
EBT excluding unusual items
27,16 մլն
23,27 մլն
32,68 մլն
31,14 մլն
Income tax expense
8,72 մլն
9,07 մլն
10,09 մլն
5,71 մլն
Effective tax rate
32,12%
38,98%
30,87%
18,34%
Other operating expenses
-
-
-
-
Net income
18,44 մլն
14,20 մլն
22,59 մլն
25,43 մլն
Net profit margin
10,19%
7,02%
10,54%
10,44%
Earnings per share
0,23
0,17
0,27
0,30
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
24,40 մլն
20,24 մլն
29,74 մլն
27,67 մլն
Gain or loss from assets sale
-43,00 հզր
-53,00 հզր
-54,00 հզր
22,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps